← Return to Chinese Medicine: Breath, Balance, and the Turning Seasons
Study · verified by the research team
Aristolochic acid-associated urothelial cancer in Taiwan
Chen CH, Dickman KG, Moriya M, et al.; Grollman AP · 2012 · Proceedings of the National Academy of Sciences USA 109(21): 8241–8246
https://doi.org/10.1073/pnas.1119920109
Molecular epidemiology linking Aristolochia herbal remedies to upper-tract urothelial carcinoma in Taiwan using DNA-adduct and TP53 mutation signatures.
Study details
| Design | Molecular epidemiological study |
|---|---|
| Population | 151 upper-tract urothelial carcinoma patients; 25 renal cell carcinoma controls |
| Outcome | Aristolactam-DNA adducts; TP53 mutation spectrum |
| Finding | TP53 signature dominated by A:T→T:A transversions, identical to that of Balkan endemic nephropathy, implicating aristolochic acid exposure |
| Limitations | Exposure history partly inferred from biomarkers |
| Certainty | high |